Which Neurology Billing Companies Actually Protect Your Diagnostic and E/M Revenue in 2026?
Neurology practices face unique reimbursement challenges that make revenue protection increasingly difficult in 2026. From complex Evaluation and Management (E/M) coding requirements to diagnostic testing reimbursement rules, even minor billing errors can lead to substantial revenue leakage. Many neurologists are finding that denials, underpayments, coding inaccuracies, and documentation deficiencies are reducing profitability despite maintaining strong patient volumes. As payer scrutiny continues to increase, practices are asking an important question: Which neurology billing companies actually protect your diagnostic and E/M revenue in 2026? The answer depends on a billing company's ability to safeguard reimbursement across the entire revenue cycle, including coding accuracy, denial prevention, diagnostic testing compliance, and revenue integrity monitoring. Why Neurology Billing Is Becoming More Challenging Neurology billing involves far more complexity than many other speci...